William McKeown/LinkedIn
Nov 2, 2026, 11:46
William McKeown: Advancing Gene and Cell Therapies for Inherited Bleeding Disorders
William McKeown, Geriatrician at National Hemophilia Centre, shared a post on LinkedIn:
“A great weekend in Bucharest for the EHC – European Haemophilia Consortium New Technologies Conference.
Pleased to co-chair a session on gene and cell therapies and hear about the latest advances in treatments for inherited bleeding disorders. Whilst it is inspiring to hear about progress made; it struck me that we need to do so much more not just for haemophilia/VWD, but even more so rare platelet disorders.
Meeting other patients is what always makes EHC meetings so valuable. Fantastic to meet colleagues and patient advocates from across Europe and beyond, including Kyrgyzstan!”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 11:41Anawat Ratchatorn: Identifying Stroke Mimics in the Emergency Department
-
Nov 2, 2026, 11:29Shruti Gadgil: AI-Powered Smartphone Screening for Anemia Severity in Rural India
-
Nov 2, 2026, 10:41Paulus Kirchhof: Smoking or Vaping – Nicotine Still Affects Vascular Health
-
Nov 2, 2026, 10:30Asesa Omullo: Connecting Sickle Cell Advocates at GANSID 2026
-
Nov 2, 2026, 10:18Salih Ehsan: Beyond IRIDA – Conditions That Mimic Iron-Refractory Anemia
-
Nov 2, 2026, 10:03Christian Heiss: Can Switching to E-Cigarettes Improve Vascular Health?
-
Nov 2, 2026, 09:56Priya Prasad: Safe Blood Begins with Informed Choices
-
Nov 2, 2026, 09:43Moath Ahmad Albliwi: More Than 10 Abstracts Accepted for ASH 2026
-
Nov 2, 2026, 02:56Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells